Milda Girdenyté
Doktorand vid Institutionen för farmaci; Farmakokinetik och Farmakodynamik; Translationell PKPD
- E-post:
- milda.girdenyte@uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
- ORCID:
- 0000-0002-3701-3847
Nyckelord
- pharmacokinetics
- drug transport
- neuropharmacokinetics
- chemotherapy-induced peripheral neuropathy
- cipn
- microtubulin-targeting agents
- mta
- cns
- pns
- blood-tissue barriers
- tubulin
- dorsal root ganglia
- sciatic nerve
- bbb
- adverse event
- drug-drug interaction

Publikationer
Senaste publikationer
Ingår i Frontiers in Pharmacology, 2024
- DOI för Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
- Ladda ner fulltext (pdf) av Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
Ingår i Fluids and Barriers of the CNS, 2024
- DOI för Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy
- Ladda ner fulltext (pdf) av Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy
Alla publikationer
Artiklar i tidskrift
Ingår i Frontiers in Pharmacology, 2024
- DOI för Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
- Ladda ner fulltext (pdf) av Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
Ingår i Fluids and Barriers of the CNS, 2024
- DOI för Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy
- Ladda ner fulltext (pdf) av Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy